MYCN and neuroblastoma: The Children’s Oncology Group stratified patients into low-, intermediate-, or high-risk groups based on age at diagnosis, International Neuroblastoma Staging System (INSS) stage [10], tumor histology, DNA index (ploidy), and MYCN (V-myc myelocytomatosis viral-related oncogene) amplification status [11].